Chi Sheng Pharma & Biotech Recognized by the Ministry of Finance as an Outstanding Business Entity for 2024
Chi Sheng Pharma & Biotech Co., Ltd. was honored by the Ministry of Finance as an “Outstanding Business Entity for 2024,” recognizing the Company’s long-standing commitment to integrity, tax compliance, and active support for government policies.

On October 8, Director-General Lee Yi-Hui of the National Taxation Bureau of the Northern Area personally visited Chi Sheng Pharma & Biotech’s place of business and presented the award plaque on behalf of the Ministry of Finance. The honor recognizes the Company’s accurate issuance of uniform invoices, cooperation with the electronic invoice policy, and contributions to national finance and economic development.
During the award presentation, the National Taxation Bureau of the Northern Area also presented a “Colorful Butterflies” long-necked celestial globe porcelain vase. Featuring auspicious motifs and butterfly imagery, the gift conveyed best wishes for continued prosperity, steady growth, and further achievements.
Integrity in Business and Commitment to Corporate Responsibility
Among the 28,705 business entities within the jurisdiction of the Zhubei Branch of the National Taxation Bureau of the Northern Area that year, only nine were selected as outstanding business entities. This recognition not only affirms Chi Sheng’s commitment to lawful operations and compliance with tax policies, but also highlights the Company’s continued efforts in corporate social responsibility and sustainable development.
Looking ahead, Chi Sheng Pharma & Biotech will continue to uphold the principles of integrity, professionalism, and sound management. While pursuing sustainable business growth, the Company will continue to fulfill its social responsibilities and create long-term value for both the industry and society.